X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

INVESTIGATIONAL NEW DRUGS

期刊標題檢索 INVEST NEW DRUG 最新評論: I also spent two months looking for reviewers and ended up having to w... (2024-05-04)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[INVESTIGATIONAL NEW DRUGS]您好,您是該頁面的第 39123 位訪客。

期刊簡介
期刊名稱INVESTIGATIONAL NEW DRUGS INVESTIGATIONAL NEW DRUGS
LetPub Score
6.6
50 ratings
Rate

Reputation
7.5

Influence
5.2

Speed
9.3

期刊簡稱INVEST NEW DRUG
ISSN0167-6997
E-ISSN1573-0646
h-index80
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.601.0860.678
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q143 / 272
Category: Medicine
Subcategory: Oncology
Q188 / 404
Category: Medicine
Subcategory: Pharmacology
Q280 / 313

自引率 (2023-2024)3.30%自引率趨勢
掲載範囲
The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents.
官方網站https://www.springer.com/10637
在線稿件提交https://www.editorialmanager.com/drug
開放訪問No
出版商Springer US
主題領域医学
出版國/地區UNITED STATES
發行頻率四半期刊行
創刊年1983
每年文章數87每年文章數趨勢
黃金OA百分比30.14%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ2142/322
PHARMACOLOGY & PHARMACYSCIEQ2136/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0167-6997%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【INVESTIGATIONAL NEW DRUGS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498359
    PHYTOMEDICINE340431
    LIFE SCIENCES285953
    International Journal of Pharmaceutics242454
    PHARMACOLOGICAL RESEARCH241405
    European Journal of Pharmacology204267
    BIOCHEMICAL PHARMACOLOGY202710
    JOURNAL OF NATURAL PRODUCTS196705
    BRITISH JOURNAL OF PHARMACOLOGY165164
    MOLECULAR PHARMACEUTICS162841
  •  

    INVESTIGATIONAL NEW DRUGS INVESTIGATIONAL NEW DRUGS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [INVESTIGATIONAL NEW DRUGS] 的評論撰寫評論
作者: 销魂力强


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-04 18:14:01 評論於
I also spent two months looking for reviewers and ended up having to withdraw the submission
(0) 讚! | 销魂力强

作者: 吴小才


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-09 13:26:24 評論於
Investigational New Drugs
View submission details
Technical check in progress 01 Apr 24
It's been over a week, still in technical check, feels so slow, anyone else in the same situation? Sent reminders but no reply
(0) 讚! | 吴小才

作者: 天山兴昌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-10 17:16:54 評論於
It's been over 2 weeks
(0) 讚! | 天山兴昌

作者: Julia


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-08 22:24:33 評論於
How long have you been investing?
(0) 讚! | Julia

作者: 天山兴昌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-03 08:50:06 評論於
I also have no one to review my manuscript. I'm really scared. Previously, when I submitted to other magazines, no one reviewed it and it was rejected, which delayed me for two months. The direction is not wrong. Why is there no one reviewing it?
(0) 讚! | 天山兴昌

作者: Julia


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-29 19:47:54 評論於
Research focus: Tumors; Drug Experience Sharing: Reviewers invited for a month without any response, will the manuscript be rejected if reviewers cannot be found?
(0) 讚! | Julia

作者: 金刚嘉澍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-11 14:18:40 評論於
Review Speed: 2.0 | Submission Hit Rate: 50.0 Emphasized Research Direction: Oncology; Drug Experience Sharing: Submitted on 23.5.1 Peer review on 23.5.4 Received comments on 23.6.12 Revision on 23.6.18 Accepted on 23.6.21 Copyright and APC issues on 23.7.12 Pubmed retrieved reviewers are still very friendly and professional, personally, I think it is very fortunate to find reviewers within a month for this journal. After acceptance, there was no movement for half a month, but once they send you the copyright, it's quick. You can choose not to pay for page charges
(0) 讚! | 金刚嘉澍

作者: 太虚伟欣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-09 22:16:09 評論於
Can case reports be submitted?
(0) 讚! | 太虚伟欣

作者: 金刚嘉澍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-23 14:30:13 評論於
Hello, may I ask how long it takes to be notified after accepting the proof? Thank you
(0) 讚! | 金刚嘉澍

作者: 韦陀梦安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-04 16:07:52 評論於
Can't you have a little heart? The magazine's emails inquiring about the progress are not replied to, but the withdrawal email was replied to very quickly. Waited four months, what a joke. This LJ magazine, everyone beware!!!
(0) 讚! | 韦陀梦安

作者: 雨巷少年兰娟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-14 23:58:35 評論於
The editing teacher is very responsible and attentive. Submissions are accepted and revised quickly, making one feel unexpectedly happy
(0) 讚! | 雨巷少年兰娟

作者: 韦陀梦安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-14 09:57:40 評論於
Review speed: 6.0 | Submission hit rate: 50.0 Emphasized research direction: Tumor Experience sharing: In early September, the manuscript was submitted for 22 years, and it has been three and a half months and still not returned for external review. I am really speechless. Looking at others, it only takes one or two months to return for external review. If it doesn't come back for external review soon, I will be really angry! ! ! ! ! ! !
(0) 讚! | 韦陀梦安

作者: 雨巷少年啸天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-06 08:27:00 評論於
Received, thank you
(0) 讚! | 雨巷少年啸天

作者: 又柔子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-01 13:11:00 評論於
Have you received it?
(0) 讚! | 又柔子

作者: 又柔子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-21 23:53:37 評論於
Please translate the following paragraph into English and Japanese, and use the titles ":" and "
(0) 讚! | 又柔子

作者: 又柔子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-21 20:36:11 評論於
Hello, how long after receiving will I be notified of proofreading? Will only the corresponding author be notified?
(0) 讚! | 又柔子

作者: 逍遥良吉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-20 14:01:35 評論於
After the system receives it, it says to check the email for next steps, but there is no email. Any fellow users experiencing this issue?
(0) 讚! | 逍遥良吉

作者: 雨巷少年啸天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-19 20:53:09 評論於
Where can I see the submission status and progress on the website? Will I be notified by email?
(0) 讚! | 雨巷少年啸天

作者: 雨巷少年啸天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-19 19:45:36 評論於
Please translate the following paragraph into English and Japanese, with titles ":" and ":"
(0) 讚! | 雨巷少年啸天

作者: 雨巷少年啸天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-19 18:25:27 評論於
Excuse me, have you found it yet?
(0) 讚! | 雨巷少年啸天

作者: 雷电雁凡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-24 11:05:48 評論於
I received an email notification that the manuscript for the magazine has been accepted, but I haven't received any further instructions in the past week. What should I do?
(0) 讚! | 雷电雁凡

作者: 北马静曼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-14 16:35:07 評論於
Hello senior, may I ask how to check the status after delivery?
(0) 讚! | 北马静曼

作者: 北马静曼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-12 19:50:37 評論於
Hello, where can I check the progress of my submission?
(0) 讚! | 北马静曼

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:35:35 評論於
Accuracy: The abstract should accurately reflect the purpose and content of the paper; 
Independence: The abstract should stand alone, so special terms, all abbreviations (except units of measurement), and omissions should be explained; 
Concise and specific: Each sentence in the abstract should provide information to the maximum extent possible and be as concise as possible; 
Tense and voice: Abstracts generally use present tense and simple past tense, and often use passive voice to describe facts
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:32:29 評論於
Different types: descriptive, informative, and structured. Descriptive abstracts are commonly used in social sciences and humanities, providing general information about the research without specific details on methodology and conclusions. Informative abstracts are typically found in scientific papers, presenting information on research background, objectives, methods, results, and conclusions. Structured abstracts focus on key information and are organized by a series of headings (e.g. research aims, methods, results, conclusions), commonly used in medical papers and clinical trial reports
(0) 讚! | 维尔娜菲茨杰拉德

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [INVESTIGATIONAL NEW DRUGS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*